This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event, March, 2022
Live In-Person: March 14-15 in Miami, FLDigital Experience: March 16-17

Networking Opportunities

Delivered as a Hybrid Event, March, 2022|Live In-Person: March 14-15 in Miami, FL, Digital Experience: March 16-17

Network With Your Leading Clinical Data Disclosure, Transparency & Plain Language Summaries Community

Benchmark, Be Inspired And Prepare To Meet Regulatory Mandates With Fellow Industry Professionals

Face-to-face and Virtual Networking Opportunities To Suit Your Every Need

Grow Your Clinical Trials Disclosure Network Through

IN-PERSON:

  • Live Q&As following presentations and panel discussions.
  • Evening Drinks Reception: Grab a drink and unwind with your peers (Monday, March 14th)
  • Networking Lunches: Enjoy your lunch with like-minded clinical data disclosure, transparency and plain language summaries professionals, solution providers and thought leaders in the exhibition hall. Take advantage of this rare opportunity to share your current challenges, benchmark solutions and grow your network.
  • Morning and Afternoon Refreshment Breaks: Take a break to digest the days sessions, grab a coffee or tea, and embrace the opportunity to meet peers impromptu once again!

DIGITAL:

  • Instant Messenger: Instant web chat directly with fellow hybrid event attendees.
  • Video Meetings: Schedule one-to-one and group video meetings for in-depth discussions.
  • Attend 3 daily live virtual sessions (March, 16-17), ask your questions in live Q&A and use room radar to see who's in the room with you.
  • Hop on a networking hub table to start a roundtable, set the topic and invite others to join you.

Who attends Clinical Data Disclosure, Transparency & Plain Language Summaries?

Join leading clinical industry professionals working in...

See Who Attended Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual 2021

A J Hunn Associates
Abbott Healthcare Pvt Ltd
AbbVie
Abhijeet Srivastava
Agios Pharmaceuticals
AHN
Aksigen Hospital Car3
Alcon
Alcon Research Ltd
Alexion Pharmaceuticals
ALK
ALK Abello
Alkermes
Almirall
Alnylam Pharmaceuticals
Amgen
Amneal Ireland Ltd.
AnaptysBio
Arena Pharmaceuticals Inc
Arnold & Porter
Ascendis Pharma
Astellas Pharma
Astra Zeneca
Astrazeneca
Autolus
Bavarian Nordic Inc
Baxter Healthcare
Bayer AG
BI
Bial-portela & Cª SA
Bill Gatton College of Pharmacy
Biocon
Biogen
Biomendex Oy
Blueberry Therapeutics Ltd
bluebird bio
Boehringer Ingelheim
Brenda Tiffin, LLC
Bristol-Myers Squibb
C Scribe Ltd
Camurus AB
Center for Information & Study on Clinical Research Participation (CISCRP)
Center for Information and Study on Clinical Research Participation
Chiesi Farmaceutici S p A
CISCRP
ClaritiDox
Cook Research
CSIC
D Wise Inc
D Wise Technologies Inc
Daiichi Sankyo
Department of Veterans Affairs
Dermavant
Devaki Thavarajah Consulting
Dompe
d-wise
East Tennessee State University
EFPIA
Egret Communications, LLC
Eisai
Eisai Europe Ltd
Eli Lilly & Company
Elisa Sala
EMTEX BV
Endo
Endo Pharmaceuticals
Esperion Therapeutics Inc
Eti Srivastava
ETSU
European Forum for Good Clinical Practice (EFGCP)
European Medicines Agency
Faculty of Medicine  University of Thessaly
FDA
Fehmina Malim
Ferring Pharmaceuticals A S
Frangipani Communications
Freeline Therapeutics Ltd
Fresenius Kabi Oncology Ltd
Galderma
Gedeon Richter Plc
Genentech
Gilead
GlaxoSmithKline
H. Lundbeck A/S
Health Literacy Media
Health Research Authority
Healthcare Business Women’s Association
Hetal Shah
Hexal AG
HKU
Hostpital HIMA San Pablo
Idorsia Pharmaceuticals Ltd
Immunicum
Informa
Inmunotek
Insmed Inc
Institute of Hematology
Ipsen

ISHA Therapeutics LLC
Janice Worley Consulting
Janssen
Johns Hopkins University
Kanica Taneja
Kateric
Kinapse
Kyowa Kirin Pharmaceutical Development
Laboratories Thea
Lay Summaries Ltd
Lehigh University
LEO Pharma
Lynn Matson
MABXIENCE
Mallinckrodt Pharmaceuticals
Maria Dolores Julian
MEDA Pharma GmbH & Co KG
Medac GmbH
Medical & Scientific Writing
Mediphacos
Merck & Co Inc
Merck Group
Merck Sharp & Dohme
Merz Pharmaceuticals
Merz Pharmaceuticals GmbH
Michelle Malanga
Multi Regional Clinical Trials Center
MyoKardia
Myovant
Namrata Avalakki
Neurocrine Biosciences
NIPER-Mohali
Novartis
Novo Nordisk
Nucana plc
Octapharma
Octapharma Pharmazeutika
OPDC
Oregon Health & Science University
Orphazyme A/S
Otsuka
Oxford PharmaGenesis
Oxford University
Paarlberg & Associates LLC
PAION
Parexel
Patient Advocates in Research
Patient Focused Medicines Development (PFMD), the Synergis
Pfizer
Pharmacosmos AS
Pierre Fabre
Privacy Analytics
Puma Biotechnology
Rega Institute
Regeneron Pharmaceuticals
Roche
ROS
Rossella Ferrari
Rudresh Kottur
Rutgers Cancer Institute of NJ
Rutgers University
Sangamo Therapeutics
Sanofi
Seagen
Seqirus Vaccines Ltd
Servier
Sheila Patterson
Shionogi Inc
Spark Therapeutics, Inc
Stanford Medicine Research Office
Sunovion Pharmaceuticals Inc
Synchrogenix a Certara Co
Takeda Pharmaceuticals
Tata Consultancy Services Ltd
Teva
TG Therapeutics
The Bloc
The University of Manchester
Thi Binh Minh Ha
TrialScope
UCB
UCB Pharmaceuticals
Umair Saleheen, MBBS
UNC Lineberger Comprehensive Cancer Center, School of Medicine
University of Crete
University of Pennsylvania
University of Sheffield
University of Wisconsin and Co-Founder and Editor-in-Chief at Dear Pandemic
UR Central Labs
US Department of Veterans Affairs
VA Puget Sound Health Care System
Vertex Pharmaceuticals
Vivli
Xogene Services
Yale Univ School of Medicine
Zealand Pharma AS
Zydus Cadila